Related Experiment Video
Updated: Feb 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Could decorin be a biomarker of coronary artery disease? A pilot study in human beings
Saeed Nazemi1, Atefeh Rezapour, Seyed Mohammad Hassan Moallem
1Department of Cardiovascular Diseases, Razavi Hospital, Iran;. saeednazemi@gmail.com.
Insights
Decorin (DCN) serum concentration was not found to correlate with coronary artery calcification (CAC) in patients with coronary artery disease. This suggests DCN is not a reliable biomarker for assessing cardiovascular event risk.
Area of Science:
- Cardiovascular research
- Biomarker discovery
- Atherosclerosis research
Background:
- Identifying patients at risk for cardiovascular events is crucial.
- Coronary artery calcification (CAC) assesses cardiovascular risk in intermediate-risk individuals.
- Decorin (DCN) is implicated in arterial calcification and atherosclerotic plaque.
Purpose of the Study:
- To investigate the correlation between serum Decorin (DCN) concentration and Coronary Artery Calcification (CAC) in humans.
- To evaluate DCN as a potential biomarker for cardiovascular disease risk.
Main Methods:
- 84 patients with coronary artery disease were included.
- Demographic data and cardiovascular risk factors were collected.
- CT-Angiography determined CAC scores; ELISA measured DCN serum levels.
Main Results:
- No significant correlation was observed between DCN serum concentration and total CAC score.
- DCN levels did not correlate with CAC in specific coronary arteries (LAD, RCA, LM, Cx).
Conclusions:
- Serum Decorin (DCN) concentration does not appear to be a suitable biomarker for coronary artery disease.
- Further research with larger sample sizes is needed to confirm these findings.
Background And Aim:
Nowadays there is a strong necessity in identifying patients who may be exposed to the risk for future cardiovascular events like progressive atherosclerotic disease. Biomarkers are valuable tools for this purpose. Coronary artery calcification (CAC) is utilized as an important tool for the global risk assessment of cardiovascular events in individuals with intermediate risk. Decorin (DCN) is a small leucine-rich proteoglycan that induces calcification of arterial smooth muscle cell and localizes to mineral deposition in human atherosclerotic plaque. The main purpose of this clinical study was to find out the correlation between Decorin serum concentration and CAC in human for the first time.
Methods:
In this study 84 patients with coronary artery disease who fulfilled inclusion and exclusion criteria, entered the study. For all patients a questionnaire consisting demographic data and traditional cardiovascular risk factors were completed. CT-Angiography was carried out to determine coronary artery calcium score and ELISA method was used for measuring DCN serum concentrations.
Results:
No significant correlation between DCN serum concentration and total CAC score and also CAC of left anterior descending, right coronary artery, left main coronary artery and circumflex was found in the study population (P>0.05).
Conclusions:
On the basis of our results DCN serum concentration is not a suitable biomarker of coronary artery disease. However, more studies with higher sample size are necessary for its confirmation.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Peripheral Artery Disease I: Introduction